OOIR: Observatory of International Research

Papers

(The TQCC of Best Practice & Research Clinical Obstetrics & Gynaecology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Primary HPV screening for cervical cancer	93
The impact of advanced maternal age on pregnancy outcome	90
Advanced maternal age and adverse pregnancy outcomes	90
Breast cancer prevention in high-risk women	84
Fertility preservation in women for medical and social reasons: Oocytes vs ovarian tissue	73
Pregnancy and Systemic Lupus Erythematosus	68
Ovarian cancer screening: Current status and future directions	65
Transforming intrapartum care: Respectful maternity care	60
Preterm birth prevention	58
Pain management during labor and vaginal birth	57
A comparison of recent guidelines in the diagnosis and management of placenta accreta spectrum disorders	54
HPV vaccination and cancer prevention	52
Long-acting reversible contraceptive (LARCs) methods	46
Progesterone and endometrial cancer	46
Risk-based breast cancer screening strategies in women	46
The epidemiology of endometriosis is poorly known as the pathophysiology and diagnosis are unclear	45
Improving access to and use of contraception by adolescents: What progress has been made, what lessons have been learnt, and what are the implications for action?	44
Endometrial cancer prevention in high-risk women	43
Menopause transition: Physiology and symptoms	42
Vaccines - safety in pregnancy	41
Uptake of vaccination in pregnancy	39
The historical aspects of vaccination in pregnancy	39
Autoimmune-mediated congenital heart block	38
Current and future approaches to screening for endometrial cancer	37
Effects of the COVID pandemic on pregnancy outcomes	37

Maternal morbidity and mortality due to placenta accreta spectrum disorders	33
Male and female condoms: Their key role in pregnancy and STI/HIV prevention	32
Assisted conception in women of advanced maternal age	30
Progesterone and abnormal uterine bleeding/menstrual disorders	29
Fertility awareness-based methods of family planning	29
Sporadic pregnancy loss and recurrent miscarriage	29
Paternal safety of anti-rheumatic medications	27
The pharmacodynamics and safety of progesterone	26
Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers	25
Hormone replacement therapy – Current recommendations	25
Pregnancy and autoimmune diseases	24
Population-based genetic testing for Women's cancer prevention	24
Progesterone use in assisted reproductive technology	23
Hepatitis B – Vertical transmission and the prevention of mother-to-child transmission	23
Clinical presentation and diagnosis of Gestational Trophoblastic Disease	22
Genetics of gestational trophoblastic disease	22
Immunology and the immunological response in pregnancy	21
Overcoming barriers to breastfeeding	21
Antiphospholipid syndrome: Diagnosis and management in the obstetric patient	20
Advances in the medical management of bowel endometriosis	20
Reduction of multiple pregnancy: Counselling and techniques	20
Breast cancer during pregnancy: epidemiology, phenotypes, presentation during pregnancy and therapeutic modalities	20
Overview of modern contraception	19
Classification of deep endometriosis (DE) including bowel endometriosis: From r-ASRM to #Enzian-classification	19
MRI of intestinal endometriosis	19
Progesterone, reproduction, and psychiatric illness	18
Non-invasive prenatal testing in the context of IVF and PGT-A	18
Post pregnancy contraception	18
Ovarian protection with gonadotropin-releasing hormone agonists during cyclophosphamide therapy in systemic lupus erythematosus	18
Treatment of low-risk gestational trophoblastic neoplasia	17
Pregnancy in myositis and scleroderma	17
Breast cancer management in 2021: A primer for the obstetrics and gynecology	17
Genetic testing for epithelial ovarian cancer	16
Antenatal diagnosis of placenta accreta spectrum (PAS) disorders	16
Cognition and mental health in menopause: A review	16
Progesterone: History, facts, and artifacts	15
Pregnancy and rheumatoid arthritis	15
Premature ovarian insufficiency	15
Deep endometriosis: The place of laparoscopic shaving	15
Adjuvant and post-surgical treatment in endometrial cancer	15
The future of electronic fetal monitoring	15
Pathology of gestational trophoblastic disease (GTD)	15
Ovarian transposition and cervical cancer	14
Vaccination in pregnancy: Challenges and evidence-based solutions	14
Ultrasonography for bowel endometriosis	13
Breast cancer screening in low and middle-income countries	13
Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance/relapsed disease	13
How to set up a regional specialist referral service for Placenta Accreta Spectrum (PAS) disorders?	13
Use of the partograph - Current thinking	13
Environmental toxicants and male fertility	13

Pregnancy outcomes following oocyte donation	13
Medications in pregnancy and breastfeeding	13
Obesity and menopause	13
Progesterone and breast	13
A review of fertility preservation in patients with breast cancer	12
Hepatitis B – chronic carrier status and pregnancy outcomes: An obstetric perspective	12
Etiopathogenesis and risk factors for placental accreta spectrum disorders	12
Placental site trophoblastic tumour and epithelioid trophoblastic tumour	12
Drug-induced liver injury in pregnancy	12
Robotic treatment of bowel endometriosis	12
Management of viral hepatitis A, C, D and E in pregnancy	11
Menopause review: Emerging treatments for menopausal symptoms	11
Autoimmune hepatitis and pregnancy	11
Desire for children and fertility preservation in transgender and gender-diverse people: A systematic review	11
Self-care provision of contraception: Evidence and insights from contraceptive injectable self-administration	11
Bowel resection for intestinal endometriosis	11
Breast cancer screening in average and high-risk women	11
Ovarian tissue and oocyte cryopreservation prior to iatrogenic premature ovarian insufficiency	10
Inflammatory diseases of the breast	10
Progression of the first stage of spontaneous labour	10
Adjuvant treatment in cervical, vaginal and vulvar cancer	10
The vanishing twin: Diagnosis and implications	10
The initiation of labour at term gestation: Physiology and practice implications	10
Translational and pharmacological principles of hyperthermic intraperitoneal chemotherapy for ovarian cancer	10
Association between the number of oocytes and cumulative live birth rate: A systematic review	9
Lessons learned from the A (H1N1) influenza pandemic	9
Placenta accreta spectrum disorders - Peri-operative management: The role of the anaesthetist	9
Augmentation of labour	9
Adjuvant and post-surgical treatment in high-grade epithelial ovarian cancer	9
Morbidity after local excision of the transformation zone for cervical intra-epithelial neoplasia and early cervical cancer	9
Reorganisation of obstetric services during the COVID pandemic – Experience from National Maternity Hospital Dublin Ireland	9
Progesterone and fetal-neonatal neuroprotection	9
Surgery including fertility-sparing treatment of GTD	9
Management of breast complaints and high-risk lesions	9
Induction of labour in low-risk pregnancies before 40 weeks of gestation: A systematic review and meta-analysis of randomized trials	9
Conservative approach: Intentional retention of the placenta	9
Role of interventional radiology in placenta accreta spectrum (PAS) disorders	9
Alternative and non-hormonal treatments to symptoms of menopause	9
COVID-19 in Women's health: Epidemiology	8
The epidemiology of obesity in reproduction	8
Psychological aspects and fertility issues of GTD	8
Male infertility and gonadotropin treatment: What can we learn from real-world data?	8
Role of adjuvant and post-surgical treatment in gynaecological cancer	8
The second stage of labor	8
Pathogenesis of bowel endometriosis	8
Future vaccines in pregnancy	8
The opioid epidemic	7
Induction of labour in pregnant individuals with obesity	7
Continuing the search for a hormonal male contraceptive	7
How and when to recommend delivery of a growth-restricted fetus: A review	7
Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology related to fresh embryo	7
Cervical ripening and labour induction: A critical review of the available methods	7
Twin reverse arterial perfusion: Timing of intervention	7
The history of labour induction: How did we get here?	7
Pregnancy-specific liver diseases	7
Management of abnormal invasive placenta in a low- and medium-resource setting	7
Contraception and preconception counseling in women with autoimmune disease	7
Neonatal management and outcome in complicated monochorionic twins: What have we learned in the past decade and what should you know?	7
Vaccinations in the newborn	7
Obesity and male infertility	7
Implications of abnormal liver function in pregnancy and non-alcoholic fatty liver disease	7
Assisted reproductive technologies for women with rheumatic AID	7
Towards an evidence-based approach to optimize the success of labour induction	7
The surgical menopause	7
Fetal reduction for everyone?	7
Adjuvant and post-surgical treatment in non-epithelial ovarian cancer	7
Monochorionic monoamniotic twin pregnancies	7